Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer

Human epidermal growth factor receptor 2 (HER2) is an oncogenic driver, and a well-established therapeutic target in breast and gastric cancers. Using functional and genomic analyses of patient-derived xenografts, we previously showed that a subset (approximately 5%) of metastatic colorectal cancer...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Oncol
Main Authors: Siena, S, Sartore-Bianchi, A, Marsoni, S, Hurwitz, H I, McCall, S J, Penault-Llorca, F, Srock, S, Bardelli, A, Trusolino, L
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Reviews
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5961091/
https://ncbi.nlm.nih.gov/pubmed/29659677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdy100
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki